BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pavel MC, Fuster J. Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions. World J Gastroenterol 2018; 24(32): 3626-3636 [PMID: 30166858 DOI: 10.3748/wjg.v24.i32.3626]
URL: https://www.wjgnet.com/1948-5182/full/v24/i32/3626.htm
Number Citing Articles
1
Wei Yang, Yingying Liu, Ruoling Gao, Zenghe Xiu, Ting Sun. Knockdown of cZNF292 suppressed hypoxic human hepatoma SMMC7721 cell proliferation, vasculogenic mimicry, and radioresistanceCellular Signalling 2019; 60: 122 doi: 10.1016/j.cellsig.2019.04.011
2
Joana Ferrer-Fàbrega, Jaime Sampson-Dávila, Alejandro Forner, Victor Sapena, Alba Díaz, Ramón Vilana, Miquel Navasa, Constantino Fondevila, Rosa Miquel, Carmen Ayuso, Juan Carlos García-Valdecasas, Jordi Bruix, María Reig, Josep Fuster. Limited tumour progression beyond Milan criteria while on the waiting list does not result in unacceptable impairment of survivalJournal of Hepatology 2021; 75(5): 1154 doi: 10.1016/j.jhep.2021.06.015
3
Javier Tejedor-Tejada, Carmen Alonso-Martín, Carolina Almohalla-Álvarez, Esteban Fuentes Valenzuela, Rodrigo Nájera Muñoz, Laura Sánchez Delgado, Carlos Maroto Martín, Fátima Sánchez-Martín, Félix García-Pajares, Gloria Sánchez-Antolín. Immunosuppressive Treatment With mTOR Inhibitors for Malignancies After Liver Transplantation: Long-Term Survival Retrospective AnalysisTransplantation Proceedings 2020; 52(5): 1507 doi: 10.1016/j.transproceed.2020.02.058
4
Hansen Dang, Yee Hui Yeo, Satoshi Yasuda, Chung‐Feng Huang, Etsuko Iio, Charles Landis, Dae Won Jun, Masaru Enomoto, Eiichi Ogawa, Pei‐Chien Tsai, An Le, Matthew Liu, Mayumi Maeda, Brian Nguyen, Nathan Ramrakhiani, Linda Henry, Ramsey Cheung, Akihiro Tamori, Takashi Kumada, Yasuhito Tanaka, Ming‐Lung Yu, Hidenori Toyoda, Mindie H. Nguyen. Cure With Interferon‐Free Direct‐Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma From Both East and WestHepatology 2020; 71(6): 1910 doi: 10.1002/hep.30988
5
Renguo Guan, Wenping Lin, Jingwen Zou, Jie Mei, Yuhua Wen, Lianghe Lu, Rongping Guo. Development and Validation of a Novel Nomogram for Predicting Vessels that Encapsulate Tumor Cluster in Hepatocellular CarcinomaCancer Control 2022; 29: 107327482211028 doi: 10.1177/10732748221102820
6
Meng-Jun Xiong, Chirag Patel, Upender Manne, Sameer Al Diffalha. Cirrhotomimetic hepatocellular carcinoma: experience of a single institution and review of the literatureHepatic Oncology 2021; 8(1) doi: 10.2217/hep-2020-0015
7
Silvia Liu, Michael A. Nalesnik, Aatur Singhi, Michelle A. Wood‐Trageser, Parmjeet Randhawa, Bao‐Guo Ren, Abhinav Humar, Peng Liu, Yan‐Ping Yu, George C. Tseng, George Michalopoulos, Jian‐Hua Luo. Transcriptome and Exome Analyses of Hepatocellular Carcinoma Reveal Patterns to Predict Cancer Recurrence in Liver Transplant PatientsHepatology Communications 2022; 6(4): 710 doi: 10.1002/hep4.1846
8
Luke V. Selby, Aslam Ejaz, Stacy A. Brethauer, Timothy M. Pawlik. Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgeryExpert Opinion on Investigational Drugs 2020; 29(2): 107 doi: 10.1080/13543784.2020.1721457
9
Shao-cheng Lyu, Jing Wang, Zhang-yong Ren, Di Cao, Qiang He. Prognosis of Liver Transplantation for Hepatocellular Carcinoma in Terms of Different Criteria: A Single Center ExperienceCurrent Medical Science 2022; 42(3): 548 doi: 10.1007/s11596-022-2558-8
10
A. Bogdanovic, P. Bulajic, D. Masulovic, N. Bidzic, M. Zivanovic, D. Galun. Liver resection versus transarterial chemoembolization for huge hepatocellular carcinoma: a propensity score matched analysisScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83868-9
11
Douglas N. VanDerwerken, Nicholas L. Wood, Dorry L. Segev, Sommer E. Gentry. The Precise Relationship Between Model for End‐Stage Liver Disease and Survival Without a Liver TransplantHepatology 2021; 74(2): 950 doi: 10.1002/hep.31781
12
Mehmet Haluk Morgul, Philipp Felgendreff, Andreas Kienlein, Ulrich Gauger, Katrin Semmling, Hans-Michael Hau, Hans-Michael Tautenhahn, Michael Bartels. Milan criteria in the MELD era—is it justifiable to extend the limits for orthotopic liver transplantation?World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01932-6
13
Tejaswini Reddy, Abdullah Esmail, Jenny C. Chang, Rafik Mark Ghobrial, Maen Abdelrahim. Utility of Cell-Free DNA Detection in Transplant OncologyCancers 2022; 14(3): 743 doi: 10.3390/cancers14030743
14
Michelle R. Ju, Adam C. Yopp. Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experienceAnnals of Gastroenterological Surgery 2020; 4(3): 208 doi: 10.1002/ags3.12316
15
Savio G. Barreto, Simone I. Strasser, Geoffrey W. McCaughan, Michael A. Fink, Robert Jones, John McCall, Stephen Munn, Graeme A. Macdonald, Peter Hodgkinson, Gary P. Jeffrey, Bryon Jaques, Michael Crawford, Mark E. Brooke-Smith, John W. Chen. Expansion of Liver Transplantation Criteria for Hepatocellular Carcinoma from Milan to UCSF in Australia and New Zealand and Justification for Metroticket 2.0Cancers 2022; 14(11): 2777 doi: 10.3390/cancers14112777
16
Maneerat Chayanupatkul, Maya Gambarin‐Gelwan, Thomas D. Schiano. The presence of non‐hepatic malignancy and its implication in pursuing liver transplantationClinical Transplantation 2021; 35(10) doi: 10.1111/ctr.14410
17
S. E. Voskanyan, E. V. Naidenov, A. I. Artemiev, I. Yu. Kolyshev, D. A. Zabezhinsky, K. K. Gubarev, V. S. Rudakov, M. V. Shabalin, A. I. Sushkov, M. V. Popov, D. S. Svetlakova, A. P. Maltseva, M. Muktarzhan, Z. Sadykhov, E. V. Vidmer. Long-term results of liver transplantation for hepatocellular cancerAnnaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2021; 26(2): 68 doi: 10.16931/10.16931/1995-5464.2021-2-68-82
18
Marco Biolato, Tiziano Galasso, Giuseppe Marrone, Luca Miele, Antonio Grieco. Upper Limits of Downstaging for Hepatocellular Carcinoma in Liver TransplantationCancers 2021; 13(24): 6337 doi: 10.3390/cancers13246337
19
Anne Quesnel-Barbet, Julien Soula, Mathurin Gamichon, Ismahane Ben Gayed, François Dufossez, Pierre Bazile, Eric-André Sauleau, Pierre Parrend, Arnaud Hansske. PoleSat_2018: an optimized, automated, geomatics IT tool based on a gravitational model: strategic decision support in hospital catchment area planningSN Applied Sciences 2020; 2(5) doi: 10.1007/s42452-020-2735-y
20
Xi-Zhen Chen, Wei Kevin Zhang, He-Bin Tang, Xiao-Jun Li, Gui-Hua Tian, Hong-Cai Shang, Yu-Sang Li. The Ethanol Supernatant Extracts of Liushenwan Could Alleviate Nanodiethylnitrosamine-Induced Liver Cancer in MiceCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6934809
21
Incheon Kang, Jae Geun Lee, Sung Hoon Choi, Hyun Jeong Kim, Dai Hoon Han, Gi Hong Choi, Myoung Soo Kim, Jin Sub Choi, Soon Il Kim, Dong Jin Joo. Impact of everolimus on survival after liver transplantation for hepatocellular carcinomaClinical and Molecular Hepatology 2021; 27(4): 589 doi: 10.3350/cmh.2021.0038
22
Alberto Zanetto, Sarah Shalaby, Martina Gambato, Giacomo Germani, Marco Senzolo, Debora Bizzaro, Francesco Paolo Russo, Patrizia Burra. New Indications for Liver TransplantationJournal of Clinical Medicine 2021; 10(17): 3867 doi: 10.3390/jcm10173867
23
Astrid Bauschke, Annelore Altendorf-Hofmann, Lukas Brückner, Robert Drescher, Martin Freesmeyer, Utz Settmacher. Impact of metabolic indices of 18F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology 2022;  doi: 10.1007/s00432-022-04009-x
24
Eric vanSonnenberg, Peter R. Mueller. Complex Therapeutic Strategies for Hepatocellular Carcinoma: Expanding CriteriaRadiology 2019; 293(3): 716 doi: 10.1148/radiol.2019192151